NPI: 1679547087 · CHINO, CA 91710 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/14/2006
Authorized official WEY, SAM controls 14+ related entities in our dataset. Read more
| Authorized Official | WEY, SAM (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/14/2006 |
Other providers sharing the same authorized official: WEY, SAM
| Provider | City | State | Total Paid |
|---|---|---|---|
| SAPELO DIALYSIS LLC | SAN LEANDRO | CA | $9.71M |
| TRAILSTONE DIALYSIS LLC | ONTARIO | CA | $2.63M |
| DVA HEALTHCARE RENAL CARE INC | SAN FRANCISCO | CA | $1.82M |
| NUEVO DIALYSIS LLC | LAGUNA HILLS | CA | $1.57M |
| CAPES DIALYSIS LLC | SEARCY | AR | $1.51M |
| TOTAL RENAL CARE INC | SANTA ROSA | CA | $818K |
| RENAL TREATMENT CENTERS-SOUTHEAST, LP. | GRETNA | LA | $796K |
| TARGHEE DIALYSIS, LLC | CINCINNATI | OH | $514K |
| GREENWOOD DIALYSIS LLC | TULSA | OK | $74K |
| DVA RENAL HEALTHCARE INC | DURHAM | NC | $10K |
| RENAL CENTER OF MOOREFIELD LLC | MOOREFIELD | WV | $8K |
| BLISS DIALYSIS LLC | BROKEN ARROW | OK | $6K |
| VILLAGEHEALTH DM LLC | DENVER | CO | $0.00 |
| SAKDC - DAVITA DIALYSIS PARTNERS LP | FLORESVILLE | TX | $0.00 |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,423 | $707K |
| 2019 | 14,319 | $527K |
| 2020 | 11,119 | $517K |
| 2021 | 11,704 | $566K |
| 2022 | 10,407 | $517K |
| 2023 | 15,144 | $633K |
| 2024 | 11,828 | $1.06M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 31,869 | 2,691 | $4.43M |
| A4657 | Syringe, with or without needle, each | 3,276 | 1,342 | $66K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,913 | 1,754 | $11K |
| 0250 | 6,001 | 354 | $9K | |
| J1756 | Injection, iron sucrose, 1 mg | 5,984 | 1,636 | $6K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 517 | 314 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,053 | 1,101 | $797.51 |
| 90674 | 12 | 12 | $28.13 | |
| 85041 | 1,053 | 988 | $26.58 | |
| 83970 | 642 | 619 | $20.34 | |
| 83550 | 386 | 369 | $12.56 | |
| 83540 | 493 | 468 | $10.42 | |
| 85048 | 1,020 | 956 | $5.28 | |
| 82728 | 462 | 441 | $4.39 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 95 | 71 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 138 | 132 | $0.00 |
| 82108 | 30 | 27 | $0.00 |